Antibody Drug Conjuagates (ADCs) Approved by FDA

The large number of emerging antibody-drug conjugates (ADCs) for cancer therapy has resulted in a significant market‘boom’, garnering worldwide attention. With significant technological advancements and an improved mechanisticunderstanding of ADC activity, after decades of research, 14 ADCs have been FDA approved, each providing demonstrabletherapeutic benefit to cancer patients. Currently, about 297 ADCs are in preclinical/clinical development, indicating that theworld is...This story is related to the following:Biopharmaceuticals
Source: Industrial Newsroom - Health, Medical and Dental Supplies - Category: Medical Devices Source Type: news